‌

US Patent 10894089 Long-acting insulin or insulin analogue conjugate

Overview Structured Data Issues Contributors

Is a

Date Filed

February 17, 2016

Date of Patent

January 19, 2021

Patent Application Number

15551489

Patent Citations

US Patent 10046061 Site-specific insulin conjugate

Patent Citations Received

US Patent 11919935 Ultra-long acting insulin-Fc fusion proteins and methods of use

0

US Patent 11352407 Ultra-long acting insulin-Fc fusion proteins

US Patent 11359001 Insulin-Fc fusions and methods of use

US Patent 11555058 Cells engineered to express ultra-long acting insulin-Fc fusion proteins

US Patent 11261229 Ultra-long acting insulin-Fc fusion proteins and methods of use

US Patent 11267862 Ultra-long acting insulin-Fc fusion proteins and methods of use

US Patent 11667689 Insulin-Fc fusion proteins and methods of use to treat cancer

0

US Patent 11673934 Ultra-long acting insulin-Fc fusion proteins and methods of use

0

US Patent 11707517 Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

0

US Patent 11773151 Ultra-long acting insulin-Fc fusion proteins and methods of use

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 10894089 Long-acting insulin or insulin analogue conjugate

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.